Bistriazenes As Chemotherapeutic Agents


The present invention is directed to bistriazene compounds, pharmaceutical compositions containing effective anti-cancer amounts of these compounds, a method for treating cancer comprising administering to affected subjects an anti-cancer effective amount of a bistriazene compound, and the use of bistriazene compounds as crosslinking reagents applicable to the synthesis and manipulation of polymeric macromolecules.

Owners (US)

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Sep 15, 1998
  • Application: Sep 12, 1994
    US US 30248094 A
  • Priority: Sep 12, 1994
    US US 30248094 A
  • Priority: Oct 31, 1991
    US US 78600191 A
  • Priority: May 24, 1990
    US US 52791590 A

Download Citation

Sign in to the Lens